ArticleJournal of biomechanics2025
Constrained optimization of scaffold behavior for improving tissue engineered vascular grafts.
Article in Journal of biomechanics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Tissue engineered vascular grafts can offer long-term benefits in matching the geometry, properties, and function of native blood vessels. Yet, choosing appropriate design parameters for biodegradeable scaffolds such that they evolve into neovessels with favorable characteristics is challenging with iterative experimental testing alone. Herein, we present an in silico framework for constrained optimization of scaffold microstructure, mechanical behavior, and degradation kinetics. Our approach combines a biomechanical model of growth and remodeling informed by large animal experiments with numerical optimization to identify design parameters that limit clinically relevant failure modes, including stenosis and dilatation, and improve functional matching to native vessel compliance. Towards this end, constraints on geometry were introduced as a straightforward way to prevent adverse remodeling outcomes and shown to be useful in shaping desired outcomes in graft remodeling. Our simulations of long-term graft evolution suggest the need for a modest initial immune response to ensure graded load transfer from polymer to neotissue and to prevent extreme changes in diameter. Optimized designs showed less sensitivity to simulated variability in their design parameters, which could limit subject-to-subject variability. Together, these findings highlight the utility of computational modeling in identifying candidate designs for improved outcomes in tissue engineered vascular grafts - elimination of stenosis/aneurysm, better compliance matching, and consistent changes in behavior over time.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.